Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (1), 1-4
- https://doi.org/10.1016/0732-8893(89)90035-7
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Mycoses Caused by Candida lusitaniaeClinical Infectious Diseases, 1987
- Fungemia in a Cancer Hospital: Changing Frequency, Earlier Onset, and Results of TherapyClinical Infectious Diseases, 1985
- In vitro and in vivo anti-Candida activity and toxicology of LY121019.The Journal of Antibiotics, 1984
- An Outbreak of Candida parapsilosis Bloodstream Infections in Patients Receiving Parenteral NutritionThe Journal of Infectious Diseases, 1984
- In vitro studies of aculeacin A, a new antifungal antibiotic.The Journal of Antibiotics, 1982
- Studies on the mechanism of antifungal action of aculeacin A.The Journal of Antibiotics, 1982
- Fungemia in the immunocompromised hostAmerican Journal Of Medicine, 1981
- Papulacandin B: an Inhibitor of Glucan Synthesis in Yeast SpheroplastsEuropean Journal of Biochemistry, 1979
- On the mode of action of a new antifungal antibiotic, aculeacin A: Inhibition of cell wall synthesis in Saccharomyces cerevisiae.The Journal of Antibiotics, 1977
- THE RATE OF BACTERICIDAL ACTION OF PENICILLIN IN VITRO AS A FUNCTION OF ITS CONCENTRATION, AND ITS PARADOXICALLY REDUCED ACTIVITY AT HIGH CONCENTRATIONS AGAINST CERTAIN ORGANISMSThe Journal of Experimental Medicine, 1948